Editas Medicine vs Verve Therapeutics

Editas Medicine vs Verve Therapeutics, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Editas Medicine is on 42/100 and Verve Therapeutics on 56/100.

Editas Medicine logo
Editas MedicineA clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.
Try Editas Medicine
Verve Therapeutics logo
Verve TherapeuticsDeveloping gene editing therapies to lower cholesterol.
Try Verve Therapeutics

Where each one leads

Editas Medicine

  • domain rating: 61/100 against 53/100

Verve Therapeutics

  • our overall score: 56/100 against 42/100
  • funding raised: $300M against $210M

At a glance

MeasureEditas MedicineVerve Therapeutics
What it isA clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.Developing gene editing therapies to lower cholesterol.
CategoryBiotech, MedTech, Genomics, Drug DiscoveryBiotechnology, Gene Therapy, Cardiovascular Disease, Drug Delivery
Sells toBusiness modelB2BB2B
OfferingPlatformServices
Founded20132018
HeadquartersCambridge, United StatesCambridge, USA
StatusActiveActive

Size, funding and growth

MeasureEditas MedicineVerve Therapeutics
Employees185Not published
Total funding$210M$300M
Latest roundSeries CSeries D
ValuationNot published$1.1B
LinkedIn followers52,616Not published

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureEditas MedicineVerve Therapeutics
StartupHub scoreOur 0-100 rating42/10056/100
Traction60/10040/100
TeamNot published20/100
Search visibility27/10012/100
Quality45/10078/100
Agent readinessHow well an AI agent can read and act on the siteF (39/100)D (42/100)
Domain ratingLink authority, 0-10061/10053/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureEditas MedicineVerve Therapeutics
CDNCloudflareCloudflare
CMSWordPressNot detected
FrameworksJquery, Tailwind CSS, BootstrapNot detected
AnalyticsGoogle Tag ManagerNot detected

Editas Medicine vs Verve Therapeutics: common questions

Which is better, Editas Medicine or Verve Therapeutics?

On our 0-100 score Verve Therapeutics rates higher (56/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.

How do Editas Medicine and Verve Therapeutics compare on the numbers?

Editas Medicine leads on domain rating (61/100 against 53/100). Verve Therapeutics leads on our overall score (56/100 against 42/100), funding raised ($300M against $210M).

Read the full Editas Medicine review and pricing or the Verve Therapeutics review and pricing. You can also browse other Editas Medicine alternatives we track.